Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 20.7% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat ...

Insulet (PODD) reported $543.9 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 25.7%. EPS of $0.90 for the same period compares to $0.71 a year ago.

Below is Validea's guru fundamental report for INSULET CORP (PODD). Of the 22 guru strategies we follow, PODD rates highest using our P/B Growth Investor model based on the published strategy of ...

In recent trading, shares of Insulet Corp (Symbol: PODD) have crossed above the average analyst 12-month target price of $320.60, changing hands for $321.41/share. When a stock reaches the target ...

Insulet PODD has outperformed the market over the past 15 years by 10.91% on an annualized basis producing an average annual return of 22.7%. Currently, Insulet has a market capitalization of $22. ...

Insulet PODD has outperformed the market over the past 15 years by 10.99% on an annualized basis producing an average annual return of 22.69%. Currently, Insulet has a market capitalization of $22 ...